For the HR + HER2-BC, the invasive size (OR 1.590, 95% CI 1.063–2.376) and TIL level (OR 0.988, 95% CI 0.978–0.998) demonstrated significant ORs in predicting a high and low Emax, respectively. This evidence concerns the gene ERBB2 and breast cancer.